TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
OncoSil Medical Ltd ( (AU:OSL) ) just unveiled an announcement.
OncoSil Medical Ltd has announced the application for quotation of 82,134 ordinary fully paid securities on the Australian Securities Exchange (ASX), following shareholder approval at the 2025 AGM. This move is part of the company’s strategic efforts to enhance its financial standing and operational capabilities, potentially impacting its market position and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:OSL) stock is a Sell with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices. The company primarily offers products aimed at improving the treatment of pancreatic and liver cancers, positioning itself as a key player in the oncology sector.
Average Trading Volume: 26,084
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$20.15M
See more data about OSL stock on TipRanks’ Stock Analysis page.